• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫体去分化中肾样腺癌。

Dedifferentiated Mesonephric-like Adenocarcinoma of the Uterine Corpus.

机构信息

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Republic of Korea.

出版信息

Anticancer Res. 2021 May;41(5):2719-2726. doi: 10.21873/anticanres.15053.

DOI:10.21873/anticanres.15053
PMID:33952503
Abstract

BACKGROUND/AIM: We present a case of uterine dedifferentiated mesonephric-like adenocarcinoma (MLA).

CASE REPORT

A 54-year-old woman underwent total hysterectomy for a uterine mass under the impression of a uterine sarcoma. Histologically, MLA exhibited various growth patterns including tubular and glandular architecture. Undifferentiated carcinoma (UC) displayed discohesive tumor cells without any obvious architecture. Immunohistochemically, UC was positive for epithelial markers in very few scattered tumor cells. MLA exhibited the wild-type p53 expression pattern, whereas UC showed a uniform and strong p53 immunoreactivity. Targeted sequencing analysis revealed an identical Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation in both components. A pathogenic missense tumor protein 53 (TP53) mutation was detected in UC, but not in MLA.

CONCLUSION

The mutant p53 expression pattern exclusively detected in UC was concordant with the presence of missense TP53 mutation. Our observations suggested that TP53 mutation is associated with the possible transformation from MLA to UC.

摘要

背景/目的:我们报告了一例子宫去分化中肾样腺癌(MLA)病例。

病例报告

一名 54 岁女性因子宫肿块接受了全子宫切除术,术前印象为子宫肉瘤。组织学上,MLA 表现出多种生长模式,包括管状和腺状结构。未分化癌(UC)显示出离散的肿瘤细胞,没有任何明显的结构。免疫组化显示,上皮标志物在极少数散在的肿瘤细胞中呈阳性。MLA 表现出野生型 p53 表达模式,而 UC 则显示均匀且强烈的 p53 免疫反应性。靶向测序分析显示两种成分均存在相同的 Kirsten 大鼠肉瘤病毒致癌基因同源物(KRAS)突变。在 UC 中检测到致病性错义肿瘤蛋白 53(TP53)突变,但在 MLA 中未检测到。

结论

仅在 UC 中检测到的突变型 p53 表达模式与错义 TP53 突变的存在一致。我们的观察结果表明,TP53 突变与 MLA 向 UC 的可能转化有关。

相似文献

1
Dedifferentiated Mesonephric-like Adenocarcinoma of the Uterine Corpus.子宫体去分化中肾样腺癌。
Anticancer Res. 2021 May;41(5):2719-2726. doi: 10.21873/anticanres.15053.
2
Serous Carcinoma of the Endometrium with Mesonephric-Like Differentiation Initially Misdiagnosed as Uterine Mesonephric-Like Adenocarcinoma: A Case Report with Emphasis on the Immunostaining and the Identification of Splice Site Mutation.子宫内膜浆液性癌伴中肾样分化,最初误诊为子宫中肾样腺癌:一例报告,重点关注免疫染色和剪接位点突变的鉴定
Diagnostics (Basel). 2021 Apr 18;11(4):717. doi: 10.3390/diagnostics11040717.
3
Mesonephric adenocarcinoma of the uterine corpus.子宫体中肾腺癌
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7012-9. eCollection 2014.
4
[Adenocarcinomas with mesonephric features in gynecologic tract: a clinicopathological analysis of seven cases].[妇科中具有中肾特征的腺癌:7例临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2021 Jul 8;50(7):791-795. doi: 10.3760/cma.j.cn112151-20201220-00944.
5
Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.卵巢低级别浆液性和中肾样混合性腺癌:中肾样腺癌来源于苗勒管的进一步证据。
Int J Gynecol Pathol. 2020 Jan;39(1):84-92. doi: 10.1097/PGP.0000000000000573.
6
Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.靶向基因组分析揭示女性生殖器官中苗勒管样腺癌的 KRAS 基因突变。
Am J Surg Pathol. 2018 Feb;42(2):227-233. doi: 10.1097/PAS.0000000000000958.
7
Mesonephric Adenocarcinoma of the Uterine Corpus: A Report on 2 Cases With Comparison to Its Cervical Counterpart.子宫体中肾腺癌:2 例报告并与宫颈 counterpart 进行比较。
Int J Gynecol Pathol. 2020 Nov;39(6):546-551. doi: 10.1097/PGP.0000000000000639.
8
Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum.子宫外中肾样肿瘤:扩展形态学谱。
Am J Surg Pathol. 2022 Jan 1;46(1):124-133. doi: 10.1097/PAS.0000000000001766.
9
Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.子宫体中肾样腺癌:237 例子宫内膜癌病例的临床病理、分子和预后特征的综合分析及回顾性复习。
Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):526-539. doi: 10.21873/cgp.20338.
10
Mixed Mesonephric-like Adenocarcinoma, Clear Cell Carcinoma, and Endometrioid Carcinoma Arising from an Endometriotic Cyst.混合性中肾样腺癌、透明细胞癌和子宫内膜样癌源于子宫内膜异位囊肿。
Int J Surg Pathol. 2024 Sep;32(6):1140-1148. doi: 10.1177/10668969231213390. Epub 2023 Nov 22.

引用本文的文献

1
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas.中肾样腺癌的乳头样和导管样模式常被忽视:对1000多例子宫内膜癌的回顾性重新评估
Histopathology. 2025 May;86(6):862-877. doi: 10.1111/his.15393. Epub 2024 Dec 17.
2
Case Report: The first report of PPP2R1A mutations in mesonephric-like adenocarcinoma of endometrial carcinoma.病例报告:子宫内膜中肾样腺癌中PPP2R1A突变的首例报告。
Front Oncol. 2023 Dec 4;13:1212648. doi: 10.3389/fonc.2023.1212648. eCollection 2023.
3
Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution.
子宫体中肾样腺癌:对来自单一机构的17例连续病例进行基因组和免疫组织化学分析及全面临床病理分析
Biomedicines. 2023 Aug 15;11(8):2269. doi: 10.3390/biomedicines11082269.
4
Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.在低级别子宫内膜样腺癌中对中肾胚基标志物表达的全面免疫组织化学分析。
Int J Gynecol Pathol. 2024 May 1;43(3):221-232. doi: 10.1097/PGP.0000000000000976. Epub 2023 Aug 11.
5
Mesonephric-like Carcinosarcoma of the Uterine Corpus: Clinicopathological, Molecular and Prognostic Characteristics in Comparison With Uterine Mesonephric-like Adenocarcinoma and Conventional Endometrial Carcinosarcoma.子宫体中肾样癌肉瘤:与子宫中肾样腺癌和传统子宫内膜癌肉瘤的临床病理、分子和预后特征比较
Cancer Genomics Proteomics. 2022 Nov-Dec;19(6):747-760. doi: 10.21873/cgp.20357.
6
Endometrioid Carcinomas of the Ovaries and Endometrium Involving Endocervical Polyps: Comprehensive Clinicopathological Analyses.卵巢和子宫内膜的子宫内膜样癌累及宫颈息肉:综合临床病理分析
Diagnostics (Basel). 2022 Sep 27;12(10):2339. doi: 10.3390/diagnostics12102339.
7
Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution.子宫体类中肾管腺癌:单中心临床病理及靶向基因组分析研究
Front Oncol. 2022 Jul 5;12:911695. doi: 10.3389/fonc.2022.911695. eCollection 2022.
8
Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.子宫体中肾样腺癌:237 例子宫内膜癌病例的临床病理、分子和预后特征的综合分析及回顾性复习。
Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):526-539. doi: 10.21873/cgp.20338.
9
Extraskeletal Mesenchymal Chondrosarcoma of the Uterus.子宫外间叶性软骨肉瘤
Diagnostics (Basel). 2022 Mar 5;12(3):643. doi: 10.3390/diagnostics12030643.
10
Mesonephric Adenocarcinoma of the Vagina Harboring Mutation.携带突变的阴道中肾腺癌
Diagnostics (Basel). 2022 Jan 5;12(1):119. doi: 10.3390/diagnostics12010119.